Apaf-1, the ced-4 human homolog, an activator of caspase-3

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A01K 67/027 (2006.01) A61K 38/17 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/62 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2293724

Novel polypeptides, designated Apaf-1, which are capable of modulating apoptosis are provided. Compositions including Apaf-1 chimeras, nucleic acid encoding Apaf-1, and antibodies to Apaf-1 are also provided.

La présente invention concerne de nouveaux polypeptides appelés Apaf-1, capables de moduler une apoptose. La présente invention concerne également des compositions comprenant des chimères d'Apaf-1, un acide nucléique codant Apaf-1 et des anticorps contre d'Apaf-1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Apaf-1, the ced-4 human homolog, an activator of caspase-3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Apaf-1, the ced-4 human homolog, an activator of caspase-3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apaf-1, the ced-4 human homolog, an activator of caspase-3 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1618878

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.